An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis - Simsek, I.; Swearingen, C.J.; Kennedy, S.; Tambiah, J.; Yazici, Y.; Lane, N.E.; Hochberg, M.C. (Osteoarthritis and cartilage, 2020)